Three concerns with regards to the utilization of COX-2 inhibitor (celecoxib) in combination with standard chemoradiotherapy for nasopharyngeal carcinoma.
| Autor: | Revannasiddaiah, Swaroop1 swarooptheone@gmail.com, Gupta, Manoj1, Seam, Rajeev1, Rastogi, Madhup1 |
|---|---|
| Zdroj: | Journal of Cancer Research & Therapeutics. Jul-Sep2012, Vol. 8 Issue 3, p464-465. 2p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|